ARCH Venture Reports a $20 Million PRME Buy

Steve Strazza
February 20, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Keith Crandell, the  co-founder and a managing director of ARCH Venture Partners.

ARCH Venture Partners just bought 3,200,000 shares of Prime Medicine Inc $PRME, equivalent to $20 million.

Article Sales Message

Know the trading behavior of …

  • Senators
  • House Of Representatives
  • C-Suite Executives
  • Hedge Fund Managers
  • Other Big-Power Players

Our experienced team of analysts work through the Form 4, 13D and 13G filings to provide you a list of the best trade ideas.

You need to have a subscription to access this content in full.

Log in or subscribe
Filed Under: